ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

Kaiser Foundation Offers Community Health Grants

April 18, 1986

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

Double Trouble For NIH: Democrats Offer Small Increases, Bush May Veto The Bill.

July 6, 2007

Hammer Says He’ll Ask Reagan For Bigger NCI Budget

October 30, 1981